Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

Citation(s) in RCA

1
(from Reference Citation Analysis)

Indexed Articles

Ranked By

Results Analysis

Year Published Analysis
Article Type Analysis
Journal Title Analysis
Category Analysis

Results Analysis

Year Published

Show more Refine

Article Statistics

Refine

Publication Titles

Show more Refine

Category

Show more Refine

For: Lode HN, Valteau-Couanet D, Garaventa A, Gray J, Castel V, Yaniv I, Siebert N, Jensen C, Endres S, Pill L, Eger C, Seidel D, Jüttner M, Kietz S, Ehlert K, Janzek E, Manzitti C, Müller I, Loibner H, Ladenstein R. Abstract A032: Immunotherapy with ch14.18/CHO in combination with IL2 is active and effective in high-risk relapsed/refractory neuroblastoma patients. Cancer Immunol Res 2016. [DOI: 10.1158/2326-6074.cricimteatiaacr15-a032] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]

For:	Lode HN, Valteau-Couanet D, Garaventa A, Gray J, Castel V, Yaniv I, Siebert N, Jensen C, Endres S, Pill L, Eger C, Seidel D, Jüttner M, Kietz S, Ehlert K, Janzek E, Manzitti C, Müller I, Loibner H, Ladenstein R. Abstract A032: Immunotherapy with ch14.18/CHO in combination with IL2 is active and effective in high-risk relapsed/refractory neuroblastoma patients. Cancer Immunol Res 2016. [DOI: 10.1158/2326-6074.cricimteatiaacr15-a032] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]

Number	Cited by Other Article(s)
1	Dinutuximab beta in high-risk neuroblastoma: a profile of its use. DRUGS & THERAPY PERSPECTIVES 2018. [DOI: 10.1007/s40267-018-0522-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/16/2022] Abstract Collapse Key Words Collapse MESH Headings Collapse Grants Collapse Affiliation(s) Collapse

Number

Cited by Other Article(s)

Dinutuximab beta in high-risk neuroblastoma: a profile of its use. DRUGS & THERAPY PERSPECTIVES 2018. [DOI: 10.1007/s40267-018-0522-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/16/2022]